%0 Journal Article %T PhysiciansĄŻ attitudes towards office-based delivery of methadone maintenance therapy: results from a cross-sectional survey of Nova Scotia primary-care physicians %A Jessica Dooley %A Mark Asbridge %A John Fraser %A Susan Kirkland %J Harm Reduction Journal %D 2012 %I BioMed Central %R 10.1186/1477-7517-9-20 %X In May 2008, facilitated by the College of Physicians and Surgeons of Nova Scotia, a cross-sectional, e-mail survey of 950 primary-care physicians practicing in Nova Scotia, Canada was administered via the OPINIO on-line survey software, to assess the acceptability of office-based MMT. Logistic regressions, adjusted for physician sociodemographic characteristics, were used to examine the association between physiciansĄŻ willingness to participate in office-based MMT, and a series of measures capturing physician attitudes and knowledge about treatment approaches, opioid use, and methadone, as well as perceived barriers to MMT.Overall, 19.8% of primary-care physicians responded to the survey, with 56% who indicated that they would be willing to be involved in MMT under current or similar circumstances; however, willingness was associated with numerous attitudinal and systemic factors. The barriers to involvement in MMT that were frequently cited included a lack of training or experience in MMT, lack of support services, and potential challenges of working with an MMT patient population.Study findings provide valuable information to help facilitate greater involvement of primary-care physicians in MMT, while highlighting concerns around administration, support, and training. Even limited uptake by primary-care physicians would greatly enhance MMT access in Nova Scotia, particularly for methadone clients located in rural communities. These findings are applicable broadly, to any jurisdictions where office-based MMT is not currently available.The impact of opioid use on Canadians is substantial; the economic costs are high and health risks include transmission of blood borne disease, overdose, premature mortality and a host of other conditions [1-5]. Methadone, a long-acting synthetic opioid agonist, is an effective treatment for opioid dependence, and evidence of positive health outcomes for opioid users and their surrounding communities is well-documented [6-13]. Howeve %K Methadone Maintenance Therapy (MMT) %K Primary care physicians %K Office-based delivery %K Access %K Barriers %U http://www.harmreductionjournal.com/content/9/1/20